Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124936162 | 12493616 | 2 | F | 20160816 | 20160623 | 20160829 | EXP | JP-JNJFOC-20160610788 | JANSSEN | TAKAYA Y, NAOHITO F, MASATOMO M, TAKENORI N, MAIKO A, YOSHINORI S, ET AL. EFFECTS OF CYP3A5 POLYMORPHISM ON THE PHARMACOKINETICS OF A ONCE-DAILY MODIFIED-RELEASE TACROLIMUS FORMULATION AND ACUTE KIDNEY INJURY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION. CANCER CHEMOTHERAPY AND PHARMACOLOGY 23-MAY-2016;78:111-118. YAMASHITA T, FUJISHIMA N, MIURA M, NIIOKA T, ABUMIYA M, NARA M. INFLUENCE OF CYP3A5 GENE POLYMORPHISMS ON PHARMACOKINETICS OF MODIFIED-RELEASE TACROLIMUS. THE JAPANESE JOURNAL OF CLINICA | 0.00 | A | Y | 0.00000 | 20160829 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124936162 | 12493616 | 1 | PS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Oral | U | U | 20083 | UNSPECIFIED | ||||||||
| 124936162 | 12493616 | 2 | I | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Intravenous drip | 0 | .03 | MG/KG | INJECTION | ||||||||
| 124936162 | 12493616 | 3 | I | GRACEPTOR | TACROLIMUS | 1 | Oral | U | 0 | CAPSULE | |||||||||
| 124936162 | 12493616 | 4 | C | MICAFUNGIN | MICAFUNGIN | 1 | Intravenous (not otherwise specified) | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124936162 | 12493616 | 1 | Infection prophylaxis |
| 124936162 | 12493616 | 2 | Prophylaxis against graft versus host disease |
| 124936162 | 12493616 | 3 | Prophylaxis against graft versus host disease |
| 124936162 | 12493616 | 4 | Antifungal prophylaxis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124936162 | 12493616 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |